Latest epilepsy Stories
Symptom improvements in-line with effects reported with stimulant drugs LOS ANGELES, May 20, 2013 /PRNewswire/ -- Today, at the American Psychiatric Association (APA) Meeting in San Francisco, James McGough, M.D., M.S., principal investigator and Professor of Clinical Psychiatry at the Semel Institute for Neuroscience and Human Behavior and David Geffen School of Medicine at the University of California Los Angeles (UCLA), and director of clinical teaching programs in both Child and...
-- Warren Lammert, Investor and Father of Child with Epilepsy, Named Chairman -- LANDOVER, Md., May 20, 2013 /PRNewswire-USNewswire/ -- The Epilepsy Foundation, a national organization dedicated to serving all people with seizures, today announced the election of its first official Board of Directors, following the completion of its merger with the Epilepsy Therapy Project. Directors from both organizations and several new nominees sit on the newly-formed board. Warren Lammert,...
Leading Philanthropists, Celebrity, Experts and People with Epilepsy Serve as Judges at Antiepileptic Drug and Device Trials (AED) XII and Pipeline Conference MIAMI, May 17, 2013 /PRNewswire-USNewswire/ -- The Epilepsy Foundation today announced the 2013 winner of the Epilepsy Therapy Project Second Annual "Shark Tank" competition for the most innovative new product idea for people with epilepsy. Utkan Demirci, Ph.D. and Steven C. Schachter, MD designed a novel point of care...
--Data Presented at AED Xll Meeting Confirms INS001 Appears Safe and Well Tolerated-- MIAMI, May 17, 2013 /PRNewswire/ -- Insero Health, Inc., a company developing natural compounds to address unmet medical needs in epilepsy and related neurological disorders, is today reporting top-line results from a Phase Ib trial of its lead compound INS001 in patients with drug-resistant epilepsy. The data are being presented at the AntiEplileptic Drug and Device Trials (AED) Xll meeting...
- Project Will Use Big Data and Analytics to Address Pressing Public Health Issue ARMONK, N.Y. and BRUSSELS, May 16, 2013 /PRNewswire/ -- regulated information -- UCB and IBM (NYSE:IBM) today announced the completion of the initial phase of a project designed to harness the power of analytics to help healthcare providers deliver more highly personalized care to people living with epilepsy. The milestone marks the critical first step in the path towards eventually harnessing the...
Free DVD and Guidebook Answers Questions for Epilepsy Patients and Families MINNEAPOLIS, May 15, 2013 /PRNewswire-USNewswire/ -- Television actor and "Dancing with the Stars" winner John O'Hurley is the host of Epilepsy: A Guide for Patients and Families, the latest free patient education DVD and guidebook produced by the American Academy of Neurology (AAN) and its foundation, the American Brain Foundation. This valuable resource answers important questions for people with newly...
A key type of human brain cell developed in the laboratory grows seamlessly when transplanted into the brains of mice, UC San Francisco researchers have discovered, raising hope that these cells might one day be used to treat people with Parkinson's disease, epilepsy, and possibly even Alzheimer's disease, as well as and complications of spinal cord injury such as chronic pain and spasticity. "We think this one type of cell may be useful in treating several types of neurodevelopmental and...
On April 20, 2013 the Epilepsy Foundation of America held its 7th National Walk for Epilepsy in Washington, DC. Team Northeast Regional Epilepsy Group (NEREG) raised over $25,000 for the American Epilepsy Society (AES) and have been awarded the 2013 Yale Cup for their fundraising achievement. New York, NY (PRWEB) May 07, 2013 On April 20, 2013 the Epilepsy Foundation of America held its 7th National Walk for Epilepsy in Washington, DC. Fourteen teams walked to raise funds for the American...
According to court data, on April 29, 2013, several plaintiffs filed a lawsuit in Illinois Southern District Court alleging serious birth defects caused by their mothers’ ingestion of Depakote during pregnancy. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Depakote side effects. San Diego, CA (PRWEB) May 07, 2013 AttorneyOne.com, a...
redOrbit Staff & Wire Reports - Your Universe Online The US Food and Drug Administration (FDA) is warning women who are of childbearing age not to use several varieties of migraine medicine which could decrease the intelligence of their babies if taken while pregnant. According to Reuters, the medications – Abbott Laboratories' Depacon, Depakote, Depakote CP, Depakote ER and Depakene, as well as Noven Therapeutics LLC's Stavzor and the generic versions of each drug – all contain...
